India's drug regulator has approved Itolizumab, a drug used to cure skin ailment psoriasis for "restricted emergency use" to treat COVID-19 patients with moderate to severe acute respiratory distress,...
from NDTV News - Special https://ift.tt/3iU2Gg6
via IFTTT
Friday, 10 July 2020
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment